In work that could lead to new treatments for sensory disorders in which people experience the strange phenomena of seeing better with one eye covered, MIT researchers report that they have identified the gene responsible for binocular vision.
Unlike horses and eagles, whose eyes on the sides of their heads provide two different scenes, humans see a single, in-depth view. Now researchers from the Picower Institute for Learning and Memory at MIT have identified the gene responsible for melding images from two eyes into one useful picture in the brain.
The work, which appeared in the Sept. 4 issue of the Public Library of Science (PloS) Biology and in the journal Cerebral Cortex, shows that a novel gene is necessary for binocular vision.
“There are other instances in the brain where two different inputs have to be properly aligned and matched—such as auditory and visual projections to the midbrain that enable us to orient to sound,” said lead author Mriganka Sur, Sherman Fairchild Professor of Neuroscience at the Picower Institute and head of the Department of Brain and Cognitive Sciences at MIT. “This is the first study to pinpoint a gene with this kind of job.”
Two points of view
Binocular vision allows us to perceive depth and carry out detailed visual processing. The images projected by each eye are aligned and matched up in brain regions called the visual thalamus and cortex.
The MIT researchers discovered that the genes Ten_m3 and Bcl6 have a key role in the early development of brain pathways for vision and touch. Ten_m3 appears to be critical for the brain to make sense of the two disparate images from each eye.
In mice that had the Ten_m3 gene knocked out, projections from their two eyes were mismatched in their brains. Because each eye’s projection suppresses the other, the mice were blind, even though their eyes worked normally.
Remarkably, the researchers found that when the output of one eye was blocked at a molecular level, the knockout mice could see again. With one eye’s conflicting input shut down, the other eye was able to function, though only with monocular vision.
“This is an amazing instance of ‘gain of function’ that proves immediately that the gene is directly responsible for creating matched projections from the two eyes,” Sur said.
Human disorders in which the Ten_m family of genes is affected are often accompanied by visual deficits. “There are reports of human visual conditions in which simply closing one eye allows a person to see much better,” Sur said. “We believe that genes such as Ten_m3 are at the heart of these disorders.”
Source: Massachusetts Institute of Technology
Related stories:
Genetic mutation identified for eye complaint
An international research collaboration including research teams from the Children's Hospital in Boston (USA), King's College London and the Peninsula Medical School, has identified a gene that, when mutated, causes Duane syndrome. The research is published in the latest edition of
Science.
Gene therapy involving antibiotics may help patients with Usher syndrome
A new approach to treating vision loss caused by Type 1 Usher syndrome (USH1), the most common condition affecting both sight and hearing, will be unveiled by a scientist at the annual conference of the European Society of Human Genetics today. Ms Annie Rebibo Sabbah, from the Genetics Department of the Rappaport Faculty of Medicine, Technion, Haifa, Israel, will tell the conference that preliminary results using a class of drugs called aminoglycosides, commonly used as antibiotics, had had promising effects in vitro and in cell culture.
Sight Recovery After Blindness Offers New Insights on Brain Reorganization
Studies of the brains of blind persons whose sight was partially restored later in life have produced a compelling example of the brain's ability to adapt to new circumstances and rewire and reconfigure itself.
Researchers find gene linked to severe diabetic eye and kidney diseases
Researchers at the John A. Moran Eye Center at the University of Utah and collaborative institutions have identified a gene called erythropoietin (EPO) that contributes to increased risk of severe diabetic eye and kidney diseases, called retinopathy and nephropathy.
When poor communication pokes you in the eye
The ocular lens belongs to the optical apparatus and focuses incidental beams of light onto the retina. Now, a research team led by Dr. Jochen Graw of the Institute of Developmental Genetics, of the Helmholtz Zentrum Munchen, has been able to decipher a genetic defect responsible for small eyes and an incomplete, clouded lens in the so-called Aey12 mouse mutants. These results lead to conclusions concerning cataracts in humans, because, in this case too, the lens loses its transparency.
Physician revolutionizes gene research
A dramatic new study published in the most recent issue of
Nature questions some of the mechanisms underlying a new class of drugs based on Nobel Prize-winning work designed to fight diseases ranging from macular degeneration to diabetes.
New cataract gene discovered
The international team of researchers was able to identify the location and defect in the coding region of the gene through analysis of genetic material (DNA) from members of a large Swiss family, the majority of whom suffered from autosomal dominant juvenile cataract. The corresponding protein belongs to a family of monocarboxylate transporters which move small molecules across cell mem-branes. Surprisingly, this genetic defect may also lead to the condition of renal glucosuria, a non-pathological kidney defect with elevated levels of glucose in the urine, but not in blood.
Gene discovery made easier with powerful new networking technique
The identification of disease-causing genes will be much easier and faster using a powerful new gene-networking model developed by researchers at The University of Texas at Austin.